2024 Speakers | Kisaco Research

2024 Speakers

Animal Health, Nutrition and Technology Innovation Europe 2025
10-12 February, 2025
London, UK
  • Author:

    Jeff Simmons

    Chief Executive Officer
    Elanco

    Jeff Simmons

    Chief Executive Officer
    Elanco
  • Author:

    Paul Casady

    Senior Consultant
    Brakke Consulting

    Paul Casady

    Senior Consultant
    Brakke Consulting
  • Author:

    Ms. Sandra Bruckner

    Managing Director
    AstraSana Animal Health AG

    Ms. Sandra Bruckner

    Managing Director
    AstraSana Animal Health AG
  • Author:

    Brian Kanke

    President
    Zoo Pharma Dynamics

    Brian Kanke

    President
    Zoo Pharma Dynamics
  • Author:

    Roxanne Feller

    Secretary General
    Animal Health Europe

    Roxanne Feller

    Secretary General
    Animal Health Europe
  • Author:

    Aaron Schacht

    CEO
    BiomEdit

    Aaron Schacht

    CEO
    BiomEdit
  • Author:

    Adrienne Woodward

    Senior Manager - Discovery & Novel Products
    United Animal Health

    Adrienne Woodward

    Senior Manager - Discovery & Novel Products
    United Animal Health
  • Author:

    Rob Kelly

    Senior Vice President, Commercial Leader for EURAM Region
    MSD Animal Health

    Rob Kelly

    Senior Vice President, Commercial Leader for EURAM Region
    MSD Animal Health
  • Author:

    Jan Moehlenbrock

    Associate Vice President, Operations EURAM
    MSD Animal Health

    Jan Moehlenbrock

    Associate Vice President, Operations EURAM
    MSD Animal Health
  • Author:

    Carel du Marchie Sarvaas

    Executive Director
    HealthforAnimals Global Animal Health Association

    Carel du Marchie Sarvaas has been working as a senior government affairs and communications advisor in Brussels and Washington DC for 20 years.

    He will move to IFAH from EuropaBio, the Association of Biotechnology Industries, where he has been Director for Agricultural Biotechnology for some 4 years. Prior to EuropaBio, Carel worked at international consultancies and think tanks in Brussels and Washington DC, most often serving clients with science-based policy and communications challenges.

    Carel du Marchie Sarvaas

    Executive Director
    HealthforAnimals Global Animal Health Association

    Carel du Marchie Sarvaas has been working as a senior government affairs and communications advisor in Brussels and Washington DC for 20 years.

    He will move to IFAH from EuropaBio, the Association of Biotechnology Industries, where he has been Director for Agricultural Biotechnology for some 4 years. Prior to EuropaBio, Carel worked at international consultancies and think tanks in Brussels and Washington DC, most often serving clients with science-based policy and communications challenges.

  • Author:

    Jürgen Horn

    CEO
    Invetx

    Jürgen Horn

    CEO
    Invetx
  • Author:

    Dr Eve Hanks

    Chief Executive Officer & Founder
    MI:RNA Diagnostics

    Dr Eve Hanks

    Chief Executive Officer & Founder
    MI:RNA Diagnostics
  • Author:

    Louisa Chaves

    Principal
    L.E.K Consulting

    Louisa Chaves

    Principal
    L.E.K Consulting
  • Author:

    Todd Richter

    Senior Managing Director
    Guggenheim Partners

    Todd Richter

    Senior Managing Director
    Guggenheim Partners
  • Author:

    Ellen de Brabander

    Executive Vice President R&D and Innovation
    Elanco

    Ellen de Brabander

    Executive Vice President R&D and Innovation
    Elanco
  • Author:

    Tobias Hestler

    Chief Financial Officer
    Haleon

    Tobias Hestler

    Chief Financial Officer
    Haleon
  • Author:

    Julie Lawless

    President
    Lawless Strategic Communications

    Julie Lawless

    President
    Lawless Strategic Communications
  • Author:

    Anshul Krishnan

    Business Development Associate
    Akston Biosciences

    Anshul Krishnan

    Business Development Associate
    Akston Biosciences
  • Author:

    Mark Heffernan

    Senior VP of Biotherapeutics and CEO of Ceva Biotechnology Campus (Philadelphia)
    Ceva

    Mark Heffernan

    Senior VP of Biotherapeutics and CEO of Ceva Biotechnology Campus (Philadelphia)
    Ceva
  • Author:

    Phil Austin

    Managing Partner & Co-Founder
    Anterra Capital

    Phil Austin

    Managing Partner & Co-Founder
    Anterra Capital
  • Author:

    Ron Phillips

    Senior Vice President, Policy
    Animal Health Institute

    Ron Phillips

    Senior Vice President, Policy
    Animal Health Institute
  • Author:

    Justine Conway

    Vice President of Business Development & External Innovation
    Elanco

    Justine Conway

    Vice President of Business Development & External Innovation
    Elanco
  • Author:

    Tim Bettington

    Executive Vice President, Corporate Strategy & Market Development
    Elanco

    Tim Bettington

    Executive Vice President, Corporate Strategy & Market Development
    Elanco
  • Author:

    Lourdes Mottier

    Business Development Head of Strategy & Chief of Staff
    Elanco

    Lourdes Mottier

    Business Development Head of Strategy & Chief of Staff
    Elanco
  • Author:

    Tom Weaver

    Co-Founder, PetMedix & Director
    BlackHawk Innovation

    Tom Weaver

    Co-Founder, PetMedix & Director
    BlackHawk Innovation
  • Author:

    Sebastian Kusmierczyk

    Vice President, Corporate & Global Innovation Strategy
    Elanco

    Sebastian Kusmierczyk

    Vice President, Corporate & Global Innovation Strategy
    Elanco
  • Author:

    Jamie Brannan

    Executive Vice President and Group President International Operations, Aquaculture and Global Diagnostics
    Zoetis

    Jamie Brannan

    Executive Vice President and Group President International Operations, Aquaculture and Global Diagnostics
    Zoetis
  • Author:

    Fabio Paganini

    Head, Latin America Region Animal Health
    Boehringer Ingelheim

    Fabio Paganini

    Head, Latin America Region Animal Health
    Boehringer Ingelheim
  • Author:

    Joe Harvey

    Head of Animal Health
    S&P Global

    Joe Harvey

    Head of Animal Health
    S&P Global
  • Author:

    Pierre Ducray

    Vice President, Global Technical Development,
    Elanco

    Pierre Ducray

    Vice President, Global Technical Development,
    Elanco
  • Author:

    Steve Nanchen

    Senior Director, External Innovation EU & APAC Pacific
    Elanco

    Steve Nanchen

    Senior Director, External Innovation EU & APAC Pacific
    Elanco
  • Author:

    Tom Seaman

    Senior Advisor, Business Development
    Elanco

    Tom Seaman

    Senior Advisor, Business Development
    Elanco
  • Author:

    Matthias Hofer

    Managing Partner
    SC Group

    Matthias Hofer is the Managing Partner at Stonehaven Consulting AG with over 15 years of experience in Animal Health. He served on the executive committees of two major Animal Health companies for a total of 7 years. Between 2009 and 2013 he led the global Aqua Health business at Novartis Animal Health (NAH). Later on, he was Global Leader Emerging Business at Elanco and a member of Elanco’s global executive committee. During 2014 and with Elanco’s intention to buy NAH, Matthias served as overall pre-merger integration leader on the Novartis side. In that role, Matthias led a large team and efforts to prepare integration pre-closing overall including carve-out preparations of operations linked to Novartis.

    Matthias Hofer

    Managing Partner
    SC Group

    Matthias Hofer is the Managing Partner at Stonehaven Consulting AG with over 15 years of experience in Animal Health. He served on the executive committees of two major Animal Health companies for a total of 7 years. Between 2009 and 2013 he led the global Aqua Health business at Novartis Animal Health (NAH). Later on, he was Global Leader Emerging Business at Elanco and a member of Elanco’s global executive committee. During 2014 and with Elanco’s intention to buy NAH, Matthias served as overall pre-merger integration leader on the Novartis side. In that role, Matthias led a large team and efforts to prepare integration pre-closing overall including carve-out preparations of operations linked to Novartis.

  • Author:

    Adrian Grosu

    Partner, SC Analytics
    SC Group

    Adrian Grosu

    Partner, SC Analytics
    SC Group
  • Author:

    Beatrice Vos, PhD

    Partner
    Stonehaven Cozmix Group (and CEO @ SC Transactions AG)

    Beatrice Vos, PhD

    Partner
    Stonehaven Cozmix Group (and CEO @ SC Transactions AG)
  • Author:

    Michael Fitzke

    Senior Director AI, Next Generation Technologies
    Mars Science & Diagnostics

    Michael Fitzke

    Senior Director AI, Next Generation Technologies
    Mars Science & Diagnostics
  • Author:

    Emmanuelle Soubeyran

    Director General
    World Organisation for Animal Health

    Emmanuelle Soubeyran

    Director General
    World Organisation for Animal Health
  • Author:

    Alan Mackay

    Executive Partner and Founder
    GHO Capital

    Alan Mackay

    Executive Partner and Founder
    GHO Capital
  • Author:

    Jesper Nordengaard

    CEO
    Dechra

    Jesper Nordengaard

    CEO
    Dechra
  • Author:

    Brandon Vasquez

    Research Analyst, Healthcare
    William Blair

    Brandon Vasquez

    Research Analyst, Healthcare
    William Blair
  • Author:

    Dave Westenberg

    Managing Director Equity Research
    Piper Sandler

    Dave Westenberg

    Managing Director Equity Research
    Piper Sandler
  • Author:

    Navann Ty

    Lead Analyst for Healthcare
    BNP Paribas

    Navann Ty

    Lead Analyst for Healthcare
    BNP Paribas